Investing Profile

Stephen Knight

InvestorVC

President and Managing Partner at F-Prime Capital Partners

fprimecapital.com/people/step...Cambridge, Massachusetts

Your Intro Paths to Stephen Knight

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Stephen Knight on

Current Investing Position

F-Prime Capital Partners Managing Partner

Investment Range

$100K - $10.0M

Sweet Spot

$5.0M

Investments On Record

Stephen Knight is on these Sector & Stage Rankings

BioTech (Series B)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)Boston / New England Health IT (Series B)

Stephen Knight's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Paradigm	Series BDec 2025$78M Series AJan 2023$200M	$320M
Co-investors: Ramnik Arora (FTX Ventures), Hemant Taneja (General Catalyst), Niko Bonatsos (General Catalyst), Elena Viboch (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Justin Kao (DFJ Growth), Robert Nelsen (ARCH Venture Partners), Alaa Halawa (Mubadala), Jay Markowitz (ARCH Venture Partners), Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh
Ensoma	Series UnknownSep 2025$53M Series BJan 2023$85M Series AFeb 2021$70M	$260M
Co-investors: Kush Parmar (5am Ventures), Mark Chin (Arix Bioscience), Kouki Harasaki (Bioluminescence Ventures)
Atalanta Therapeutics	Series BJan 2025$97M Series AJan 2021$110M	$210M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners), Jason P. Hafler (Sanofi Ventures), Niall O’Donnell (RiverVest)
Quantum Circuits	Series BMay 2024$60M	$60M
Co-investors: Corey Ritter (ARCH Venture Partners), Eugene Chiu (In-Q-Tel)
Genomics	Series CJan 2024$45M Series UnknownMar 2021$30M Series BDec 2018$9M	$84M
Co-investors: Jim Tananbaum (Foresite Capital)
Aerium Therapeutics	Series AMar 2022
Co-investors: Vincent Ossipow (Omega Funds), Michael Powell (Omega Funds)
Leyden Labs	Series BJan 2022$140M Series AMar 2021$47M	$260M
Co-investors: David Schenkein (GV (Google Ventures)), Nisa Leung (Qiming Venture Partners), Brook Byers (Kleiner Perkins)
Prime Medicine	Series BJul 2021$200M Series AOct 2019$120M	$320M
Co-investors: David Schenkein (GV (Google Ventures)), Stephen Francis (Arrive), Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive)